Enterovirus 71 meningoencephalitis complicating rituximab therapy

被引：17

作者：

Ahmed, Rebekah ^{[1
]}

Buckland, Michael ^{[2
]}

Davies, Leo ^{[1
]}

Halmagyi, G. Michael ^{[1
]}

Rogers, Shannon L. ^{[3
]}

Oberste, Steven ^{[3
]}

Barnett, Michael H. ^{[1
]}

机构：

[1] Univ Sydney, Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW 2006, Australia

[2] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia

[3] Ctr Dis Control & Prevent, Atlanta, GA USA

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2011年 / 305卷 / 1-2期

关键词：

Enterovirus; 71; Encephalitis; Rituximab; Monoclonal antibody; ANTI-CD20; MONOCLONAL-ANTIBODY; DIRECT IDENTIFICATION; AMPLIFICATION; SEROTYPES; LYMPHOMA;

D O I：

10.1016/j.jns.2011.03.009

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We describe a fatal case of proven enterovirus 71 meningoencephalitis complicating monoclonal anti-CD20 antibody therapy for non-Hodgkin's lymphoma. B-cell depletion, an effective treatment strategy in an expanding spectrum of hematological and inflammatory disorders, impairs neutralising antibody-mediated clearance of enterovirus. The global threat of emerging neurotropic viruses such as enterovirus 71 is heightened by an increasing pool of susceptible individuals in non-endemic regions. (C) 2011 Elsevier B.V. All rights reserved.

引用

页码：149 / 151

页数：3

共 12 条

[1] Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy
Ganjoo, Kristen N.
Raman, Raghav
Sobel, Raymond A.
Pinto, Harlan A.
[J]. LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 673 - 675
[2] Neurologic complications in children with enterovirus 71 infection
Huang, CC
Liu, CC
Chang, YC
Chen, CY
Wang, ST
Yeh, TF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (13) : 936 - 942
[3] Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region
Leitch, E. C. McWilliam
Harvala, H.
Robertson, I.
Ubillos, I.
Templeton, K.
Simmonds, R.
[J]. JOURNAL OF CLINICAL VIROLOGY, 2009, 44 (02) : 119 - 124
[4] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program
McLaughlin, P
Grillo-López, AJ
Link, BK
Levy, R
Czuczman, MS
Williams, ME
Heyman, MR
Bence-Bruckler, I
White, CA
Cabanillas, F
Jain, V
Ho, AD
Lister, J
Wey, K
Shen, D
Dallaire, BK
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2825 - 2833
[5] An overview of the evolution of enterovirus 71 and its clinical and public health significance
McMinn, PC
[J]. FEMS MICROBIOLOGY REVIEWS, 2002, 26 (01) : 91 - 107
[6] Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens
Nix, W. Allan
Oberste, M. Steven
Pallansch, Mark A.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) : 2698 - 2704
[7] Oberste AS, 2005, REV MED MICROBIOL, V16, P163
[8] Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab
Padate, BP
Keidan, J
[J]. CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (01): : 69 - 71
[9] Outbreak of neurologic enterovirus type 71 disease:: A diagnostic challenge
Perez-Velez, Carlos M.
Anderson, Marsha S.
Robinson, Christine C.
McFarland, Elizabeth J.
Nix, W. Allan
Pallansch, Mark A.
Oberste, M. Steven
Glode, Mary P.
[J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (08) : 950 - 957
[10] Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action
Pescovitz, MD
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 859 - 866

← 1 2 →